Bio-Rad Laboratories | Des Atouts



Assets Changement Date
Abbott USD 81.41B 7.06B 2024-12
Agilent USD 11.91B 68M 2025-01
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Bio Techne USD 2.67B 65.59M 2024-12
Bio-Rad Laboratories USD 9.36B 1.24B 2024-12
Bruker USD 5.81B 302.5M 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Danaher USD 77.54B 3.07B 2024-12
Exact Sciences USD 5.93B 820.43M 2024-12
General Electric USD 123.14B 3.56B 2024-12
Hologic USD 8.73B 427.3M 2024-12
Illumina USD 6.3B 289M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
Laboratory Of America USD 18.38B 233.5M 2024-12
Merck USD 117.11B 426M 2024-12
Mettler Toledo International USD 3.24B 79.83M 2024-12
Myriad Genetics USD 1.03B 53.7M 2024-12
Quest Diagnostics USD 16.15B 58M 2024-12
Repligen USD 2.83B 978K 2024-12
Revvity USD 12.39B 377.26M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Siemens EUR 157.86B 10.04B 2024-12
Standard Biotools USD 612.34M 69.19M 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
Tosoh JPY 1.33T 93M 2024-12
Waters USD 4.55B 42.18M 2024-12



Bio-Rad Laboratories Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.